Back to Search Start Over

Improving 10-year atherosclerotic cardiovascular disease estimation management using a Smartphrase for automated risk screening.

Authors :
Chappell AL
Source :
Journal of the American Association of Nurse Practitioners [J Am Assoc Nurse Pract] 2022 Oct 01; Vol. 34 (10), pp. 1151-1155. Date of Electronic Publication: 2022 Oct 01.
Publication Year :
2022

Abstract

Background: Cardiovascular disease (CVD) is the most common cause of death in the United States, and 90% of cardiovascular events are preventable. The 2020 American College of Cardiology/American Heart Association Guidelines on the Primary Prevention of Cardiovascular Disease recommends 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimates for 40- to 75-year-old adults with CVD risk indications to decrease the likelihood of cardiovascular events.<br />Local Problem: At the project site, the 10-year ASCVD risk estimates were rarely completed by providers. The purpose of this project was to increase 10-year ASCVD risk estimation screening and improve pharmacological therapy for 40- to 75-year-old patients with CVD risk indications.<br />Methods: To increase 10-year ASCVD risk estimation screening and improve pharmacological therapy, a multifaceted bundle was created for providers.<br />Interventions: Three interventions were initiated: an electronic health record Smartphrase was created to produce automatic 10-year risk scores; laminated paper reminders for the Smartphrase were visible on providers' desks; educational in-services were performed to promote risk score adherence.<br />Results: The project aims were achieved with an increase from a 14% completion rate for 10-year ASCVD risk estimation during the preintervention phase to a 98% completion rate at the end of the postintervention phase. Appropriate pharmacological therapy improved from a 64% rate during the preintervention phase to a maximum rate of 79% during postintervention.<br />Conclusion: The project was effective at increasing risk estimate completion and improving appropriate pharmacological therapy. There was an increase in provider-patient discussions toward primary prevention for cardiovascular events.<br />Competing Interests: Competing interests : The author reports no conflicts of interest.<br /> (Copyright © 2022 American Association of Nurse Practitioners.)

Details

Language :
English
ISSN :
2327-6924
Volume :
34
Issue :
10
Database :
MEDLINE
Journal :
Journal of the American Association of Nurse Practitioners
Publication Type :
Academic Journal
Accession number :
35834421
Full Text :
https://doi.org/10.1097/JXX.0000000000000757